Jim Sweeney’s Post

Ema Rastoder har publiceret en artikel hos Copenhagen Respiratory Research COP RESP om koagulationen hos patienter med kronisk obstruktiv lungesygdom i rolig fase og i forbindelse med en forværring. Ema Rastoder has published an article with Copenhagen Respiratory Research COP RESP on coagulation patterns in patients with COPD during steady fase and in relation to an exacerbation. https://lnkd.in/eMnMbqis

ndd #blog tip of the week: 📈Studies show that improving #COPD diagnosis in primary care could significantly reduce exacerbations and lighten the economic burden of the disease. Early detection is key to better outcomes and cost savings. Let’s prioritize spirometry testing and make a real difference in the lives of those affected by COPD! 👉 Learn more in our blog: https://nddmed.co/0jwlcd #ndd #EarlyDiagnosis #PrimaryCare #Spirometry #COPDAwarenessMonth #EasyOne #Blog

Thrilled to announce the publication of our latest study on pulmonary rehabilitation (PR) and its long-term impact on survival in chronic respiratory disease patients! PR has long been recognized for its immediate benefits in improving symptoms, exercise tolerance, and quality of life. However, there has been limited evidence on its potential for long-term outcomes, particularly in terms of survival. In our 20-year retrospective study, we aimed to address this gap by comparing the mortality rates of patients who participated in PR with a matched control group who did not. The findings were significant: patients who underwent PR showed substantially lower mortality rates, even when adjusting for factors like age, sex, lung function, and smoking history. This survival advantage was observed across different patient groups, including those with COPD, further underscoring PR’s critical role in managing chronic respiratory diseases. Our study highlights the lasting benefits of PR, not just as a short-term intervention but as a long-term strategy that can enhance survival and quality of life for patients with chronic lung conditions. I’m proud of the work our team has done and excited to share these results with the broader healthcare community. You can read the full study here: https://lnkd.in/grcVTgFP #PulmonaryRehabilitation #ChronicRespiratoryDisease #COPD #LungHealth #SurvivalAnalysis #CoxRegression #Healthcare

Struggling with COPD? Understanding is the first step to managing COPD effectively. Our blog provides expert insights into symptoms, treatments, and ongoing research. Equip yourself with knowledge and take control of your health. Learn more: https://lnkd.in/gWSDDcPp #medicalresearch #clinicaltrials #medicalstudies #miamiclinicalresearch #copd #copdclinicalstudies #copdresearch #lunghealth #copdtreatment #copdsymptoms #copdmanagement #respiratoryhealth

🌬️ Enhancing COPD Care: Best Practices in Differential Diagnosis 🌬️ Managing exacerbations in Chronic Obstructive Pulmonary Disease (COPD) is a critical challenge, especially in acute care settings. Research highlights that up to 70% of hospital readmissions following COPD exacerbations are due to decompensation of comorbidities, not the exacerbation itself. Identifying and addressing these underlying morbidities can significantly improve patient outcomes. The article outlines a systematic approach to evaluating worsening respiratory symptoms in COPD patients, emphasizing precise diagnosis and targeted treatment strategies. This perspective integrates dispersed knowledge into a cohesive framework, benefiting clinicians and patients alike. Healthcare professionals can also earn AMA PRA Category 1 CME credits while deepening their expertise on this vital topic. 🔗 https://lnkd.in/dgPixcpU #COPD #ChronicObstructivePulmonaryDisease #HealthcareInnovation #DifferentialDiagnosis #PatientCare

I recently read an article on how the number of global COPD patients is projected to reach nearly 600 million by 2050. According to data from 2020, COPD impacted approximately 480 million people around the world, equating to 10.6% of the total population (and a whopping 16.8% of North Americans). These numbers are big, but they aren’t surprising to someone who works in the #copd space. In general, I believe there needs to be greater awareness of COPD – not only of the risk factors to help prevent the disease but also increased knowledge of symptoms so the condition can be managed better, earlier. If COPD rates continue to rise, it’s evident that a greater burden will be placed on patients, providers, and hospitals. Luckily, in the words of Dr. Diego Maselli Caceres, a thought leader in this area and nationally recognized pulmonologist at @UT Health in San Antonio, "There has never been a better time to be diagnosed with COPD." This is because of proven digital continuous monitoring platforms like Spire Health that can better serve this challenging patient population.  Check out the full @COPDNewsToday piece by Margarida Maia, PhD here: https://lnkd.in/eH3eN_Pd

"Bronchiectasis is massively underdiagnosed." Prof. James D Chalmers, Asthma + Lung UK Chair of Respiratory Research, University of Dundee, highlights the huge need for better diagnostics for bronchiectasis - the UK's 3rd most common chronic lung condition. Despite its prevalence, bronchiectasis remains neglected and diagnosis is challenging as symptoms overlap with other lung diseases like asthma, emphysema, and chronic obstructive pulmonary disease (COPD). This often leads to misdiagnosis or delayed diagnosis, which can worsen patient outcomes and increase the burden on healthcare systems. Currently, a CT scan is the only definitive diagnostic tool, but it is costly and resource-intensive. We urgently need faster, cheaper, and more accurate diagnostics. These would reduce reliance on expensive CT scans and speed up diagnosis, helping patients get quicker access to treatment. We also need improved tests for managing infections and exacerbations. Find out more about the needs and opportunities in bronchiectasis research here: https://lnkd.in/eMDiNj84

The Maverex team has recently been involved in the development of an interesting publication on the temporal dynamics of cardiovascular risk in patients with COPD. The full paper can be found at the link below: https://lnkd.in/eNNDd8rd #copd #cardiovascularrisk #literaturereview

Another reason early identification and monitoring of COPD patients is so important! In addition to helping with HEDIS measures for spirometry, generally improving patient outcomes, and reducing ER and hospitalizations/readmissions *for COPD*... helping COPD maintain good control through frequent monitoring and treatment plan updates can also help in reducing comorbidity-related admissions and readmissions for conditions like ACS and HF.

If you have committed your life to improving the Quality of Life in COPD patients, this is a recent paper about the interaction between QoL and Meaning in Life (MIL) in COPD you need to familiarize yourself with: https://lnkd.in/g6JTBnBU #COPD #QoL #MayoClinic #TheBiggerPicture